<DOC>
	<DOCNO>NCT01510171</DOCNO>
	<brief_summary>The aim RAPID study ass rapid onset action 2 novel oral antiplatelet agent , Prasugrel Ticagrelor , 50 patient STEMI undergo PPCI bivalirudin monotherapy .</brief_summary>
	<brief_title>Rapid Activity Platelet Inhibitor Drugs Study</brief_title>
	<detailed_description>Fifty consecutive patient STEMI undergo PPCI bivalirudin ( GP IIb/IIIa allow ) randomize receive 60 mg Prasugrel load dose ( n= 25 ) 180 Ticagrelor load dose ( n= 25 ) PPCI . The load dose perform soon possible Emergency Room Cath Lab . In case vomit 2 hour drug load dose new load dose administer . All intervention perform femoral approach accord current standard . The use thrombectomy infarct-related artery stenting , everolimus elute stent closure device strongly encourage . Bivalirudin administer bolus 0.75 mg/kg follow 1.75 mg/kg/h infusion PCI . After PCI reduce bivalirudin infusion 0.25 mg/kg/h 4 hour allow . Dual antiplatelet therapy ( 100 mg aspirin associate 5 10 mg Prasugrel 180 mg Ticagrelor ) recommend 12 month . Residual platelet reactivity assess patient baseline ( time load dose ) , 2 , 4 , 8 12 hour point-of-care test VerifyNow bedside available Intensive cardiac care Unit . High residual platelet reactivity define Platelet Reactivity Units ( PRU ) &gt; 240 VerifyNow . At time point , Activated Clotting Time ( ACT ) also assess . Follow-up perform outpatient visit telephone interview 6 month .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>1 . Patients present within 12 hour onset symptom STEMI 2 . Informed , write consent 1 . Age &lt; 18 year 2 . Active bleeding ; bleed diathesis ; coagulopathy 3 . History gastrointestinal genitourinary bleeding &lt; 2 month 4 . Major surgery last 6 week 5 . History intracranial bleed structural abnormality 6 . Suspected aortic dissection 7 . Any previous TIA/stroke 8 . Administration week index event clopidogrel , ticlopidine , prasugrel , ticagrelor , thrombolytic , bivalirudin , lowmolecular weight heparin fondaparinux , GPI . 9 . Known relevant hematological deviation : Hb &lt; 10 g/dl , Platelet count &lt; 100x10^9/l 10 . Use coumadin derivative within last 7 day 11 . Chronic therapy prasugrel ticagrelor 12 . Known malignancy comorbid condition life expectancy &lt; 1 year 13 . Known severe liver disease , severe renal failure 14 . Known allergy study medication 15 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>platelet inhibitor</keyword>
	<keyword>ST-segment elevation myocardial infarction</keyword>
	<keyword>stent</keyword>
	<keyword>prasugrel</keyword>
	<keyword>ticagrelor</keyword>
</DOC>